DE60219927D1 - Verfahren zur herstellung von glycopeptid- phosphonat-derivaten - Google Patents

Verfahren zur herstellung von glycopeptid- phosphonat-derivaten

Info

Publication number
DE60219927D1
DE60219927D1 DE60219927T DE60219927T DE60219927D1 DE 60219927 D1 DE60219927 D1 DE 60219927D1 DE 60219927 T DE60219927 T DE 60219927T DE 60219927 T DE60219927 T DE 60219927T DE 60219927 D1 DE60219927 D1 DE 60219927D1
Authority
DE
Germany
Prior art keywords
preparation
phosphonate derivatives
glycopeptide phosphonate
glycopeptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60219927T
Other languages
English (en)
Other versions
DE60219927T2 (de
Inventor
Michael Leadbetter
Martin Linsell
Junning Lee
Jyanwei Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoviva Inc
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of DE60219927D1 publication Critical patent/DE60219927D1/de
Publication of DE60219927T2 publication Critical patent/DE60219927T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60219927T 2001-08-24 2002-08-23 Verfahren zur herstellung von glycopeptid- phosphonat-derivaten Expired - Lifetime DE60219927T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31483101P 2001-08-24 2001-08-24
US314831P 2001-08-24
PCT/US2002/026853 WO2003029270A2 (en) 2001-08-24 2002-08-23 Process for preparing glycopeptide phosphonate derivatives

Publications (2)

Publication Number Publication Date
DE60219927D1 true DE60219927D1 (de) 2007-06-14
DE60219927T2 DE60219927T2 (de) 2008-01-17

Family

ID=23221639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60219927T Expired - Lifetime DE60219927T2 (de) 2001-08-24 2002-08-23 Verfahren zur herstellung von glycopeptid- phosphonat-derivaten

Country Status (15)

Country Link
US (5) US6979723B2 (de)
EP (1) EP1418933B1 (de)
JP (2) JP4116555B2 (de)
KR (1) KR100909438B1 (de)
CN (1) CN1246036C (de)
AT (1) ATE361312T1 (de)
AU (1) AU2002326739B2 (de)
BR (1) BRPI0211997B8 (de)
CA (1) CA2457863C (de)
DE (1) DE60219927T2 (de)
DK (1) DK1418933T3 (de)
ES (1) ES2286274T3 (de)
NO (1) NO331661B1 (de)
TW (1) TWI275594B (de)
WO (1) WO2003029270A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
US6951963B2 (en) 2002-06-17 2005-10-04 Theravance, Inc. Process for preparing N-protected β-amino aldehyde compounds
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
EP2753637A1 (de) 2011-09-09 2014-07-16 Sandoz AG Verfahren zur synthese von telavancin, seine pharmazeutisch akzeptablen salze sowie ein n-geschütztes iminderivat von telavancin
EP2753638A1 (de) 2011-09-09 2014-07-16 Sandoz AG Verfahren zur synthese von telavancin und seinen pharmazeutisch akzeptablen salzen sowie n-geschützte derivate daraus
TWI641372B (zh) 2013-03-15 2018-11-21 美商梅琳塔有限責任公司 使用抗生素治療超重和肥胖患者感染的方法
WO2016063246A1 (en) * 2014-10-22 2016-04-28 Sun Pharmaceutical Industries Limited Crystalline form r of tedizolid phosphate
US20160243190A1 (en) 2015-02-23 2016-08-25 Theravance Biopharma Antibiotics Ip, Llc Doses and methods for administering telavancin
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN106631902A (zh) * 2016-09-23 2017-05-10 上海步越化工科技有限公司 一种特拉万星侧链癸基(2‑氧代乙基)氨基甲酸9h‑芴‑9‑甲基酯的制备方法
CN107629116B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法
CN107629115B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3160632A (en) 1961-01-30 1964-12-08 Stauffer Chemical Co Aminomethylenephosphinic acids, salts thereof, and process for their production
US4643967A (en) * 1983-07-07 1987-02-17 Bryant Bernard J Antibody method for lowering risk of susceptibility to HLA-associated diseases in future human generations
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
IL78597A0 (en) 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
EP0376041B1 (de) 1988-12-27 1996-02-28 GRUPPO LEPETIT S.p.A. C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
NZ236393A (en) 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
UA41283C2 (uk) 1991-07-29 2001-09-17 Біосерч Італіа С.П.А. Похідні антибіотику а 40926 та способи їх одержання
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
RU2145609C1 (ru) 1994-01-28 2000-02-20 Эли Лилли Энд Компани Производные гликопептида или их соли, способ получения, фармацевтическая композиция
US5561714A (en) * 1994-12-12 1996-10-01 Tektronix, Inc. Scrambling system for serial digital video
US5919756A (en) 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
AU3307399A (en) * 1998-02-20 1999-09-06 Advanced Medicine, Inc. Novel antibacterial agents
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
HU230190B1 (hu) 1998-12-23 2015-09-28 Theravance, Inc Glikopeptidszármazékok és ezeket tartalmazó gyógyászati kompozíciók
JP2000281694A (ja) * 1999-03-29 2000-10-10 Tanaka Kikinzoku Kogyo Kk 有機金属気相エピタキシー用の有機金属化合物
AU4054900A (en) 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
DE60135102D1 (de) 2000-05-02 2008-09-11 Theravance Inc Verfahren zur reduktiven alkylierung von glykopeptiden
SI1278549T1 (sl) * 2000-05-02 2009-04-30 Theravance Inc Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik
WO2001098329A1 (en) * 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
US7726104B2 (en) * 2006-06-21 2010-06-01 Cp Packaging, Inc. Vacuum packaging system with end cutter

Also Published As

Publication number Publication date
KR20040028999A (ko) 2004-04-03
ES2286274T3 (es) 2007-12-01
US20080227963A1 (en) 2008-09-18
JP4116555B2 (ja) 2008-07-09
US20110060122A1 (en) 2011-03-10
EP1418933B1 (de) 2007-05-02
US7728104B2 (en) 2010-06-01
BRPI0211997B8 (pt) 2016-11-16
US20060264607A1 (en) 2006-11-23
BRPI0211997B1 (pt) 2016-10-11
JP2008208130A (ja) 2008-09-11
AU2002326739B2 (en) 2007-10-18
BR0211997A (pt) 2006-04-04
EP1418933A2 (de) 2004-05-19
DK1418933T3 (da) 2007-06-11
EP1418933A4 (de) 2004-10-27
TWI275594B (en) 2007-03-11
KR100909438B1 (ko) 2009-07-28
US20030069391A1 (en) 2003-04-10
JP2005526000A (ja) 2005-09-02
DE60219927T2 (de) 2008-01-17
US8093354B2 (en) 2012-01-10
US6979723B2 (en) 2005-12-27
NO331661B1 (no) 2012-02-20
US20050020488A1 (en) 2005-01-27
WO2003029270A2 (en) 2003-04-10
NO20040766L (no) 2004-04-29
CN1246036C (zh) 2006-03-22
ATE361312T1 (de) 2007-05-15
CA2457863C (en) 2012-01-03
WO2003029270A3 (en) 2003-09-04
CA2457863A1 (en) 2003-04-10
CN1547481A (zh) 2004-11-17
US7301004B2 (en) 2007-11-27
US7074890B2 (en) 2006-07-11

Similar Documents

Publication Publication Date Title
DE60219927D1 (de) Verfahren zur herstellung von glycopeptid- phosphonat-derivaten
DE60018119D1 (de) Verfahren zur herstellung von polymorphen des clarithromycins
ATE449167T1 (de) Verfahren zur herstellung von l-aminosäuren mit stämmen der familie enterobacteriaceae
DE50312217D1 (de) Verfahren zur herstellung von 1-olefinen durch katalytische spaltung von 1-alkoxyalkanen
IL140419A0 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
ATE360653T1 (de) Verfahren zur herstellung von polyisobutenen
ATE440078T1 (de) Verfahren zur herstellung von alkylaminen
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
DE60219638D1 (de) Verfahren zur herstellung von glycopeptidderivaten
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
ATE335745T1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
DE602004003037D1 (de) Verfahren und zwischenprodukte für die herstellung von emtricitabin
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
ATE272038T1 (de) Verfahren zur herstellung von 2-alkyl-3- chlorphenolen
ATE425143T1 (de) Verfahren zur herstellung von indolen
DE69927247D1 (de) Verfahren zur herstellung von fleischprodukten
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE50203529D1 (de) Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
ATE282026T1 (de) Verfahren zur herstellung von halo-4-phenoxy- chinolinen
DE60116787D1 (de) Verfahren zur herstellung von pravastatin-natriumsalz mittels streptomyces flavidovirens dsm 14455
ATE326449T1 (de) Verfahren zur herstellung von substituierten cyclopentadienverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN